Only months after he had gotten clean himself, Robert F. Kennedy Jr. and the Kennedy family lost his younger brother to addiction at a Palm Beach hotel in 1984. RFK Jr., a likely candidate for a health-related position in the new Trump administration ...

RFK Jr. has said Trump promised him “control of the public health agencies,” including the National Institutes of Health and the Centers for Disease Control and Prevention. He’s talked about cleaning up “corruption” at those agencies and reorienting them towards a chronic disease focus (in a page on his MAHA website that has since been scrubbed).

RFK Jr., a longtime anti-vaccine activist, to play a role in Trump administration and potentially influence how the FDA and CDC approach the lifesaving shots.

Robert F. Kennedy Jr, the former independent presidential candidate, is reviewing candidate resumes for the top jobs at the U.S. government's health agencies in Donald Trump's new administration, a former Kennedy aide and a source familiar with the matter told Reuters on Friday.

Robert F. Kennedy Jr., who will meet with senior Trump aides Wednesday to discuss his role going forward, said he would eliminate the nutrition departments at the FDA.

"On January 20, the Trump White House will advise all U.S. water systems to remove fluoride from public water. Fluoride is an industrial waste associated with arthritis, bone fractures, bone cancer, IQ loss, neurodevelopmental disorders, and thyroid disease," Kennedy said on social media over the weekend.

Trump said Robert F. Kennedy Jr. would be allowed to reshape the country's public health and "do some things."

Members of the Kennedy family, the prominent political lineage rooted here in Massachusetts, are reacting to Donald Trump's win

Robert F. Kennedy Jr. may have a significant influence on public health matters following Donald Trump's presidential victory.

In an interview with NPR on Wednesday, Kennedy said Trump had already assigned him three tasks: to reduce the “corruption and conflicts” in regulatory agencies like the FDA, return those agencies to the “evidence-based science and medicine that they were once famous for,” and to end chronic disease with measurable impacts within two years.

One senior executive from the healthcare sector told the Financial Times his influence on policy would be “awful on a lot of levels."